Prophase Labs Inc
NASDAQ:PRPH

Watchlist Manager
Prophase Labs Inc Logo
Prophase Labs Inc
NASDAQ:PRPH
Watchlist
Price: 0.615 USD -10.48% Market Closed
Market Cap: 28.4m USD

Wall Street
Price Targets

PRPH Price Targets Summary
Prophase Labs Inc

There are no price targets for PRPH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Prophase Labs Inc Competitors:
Price Targets
3933
United Laboratories International Holdings Ltd
60% Upside
000739
Apeloa Pharmaceutical Co Ltd
18% Upside
JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
13% Upside
4016
Middle East Pharmaceutical Industries Company SJSC
12% Upside
MEGA
Mega Lifesciences PCL
7% Upside

Revenue
Forecast

Revenue Estimate
Prophase Labs Inc

For the last 13 years the compound annual growth rate for Prophase Labs Inc's revenue is -7%. The projected CAGR for the next 1 year is 222%.

-7%
Past Growth
222%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Prophase Labs Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
39%
Average Beat

Net Income
Forecast

Net Income Estimate
Prophase Labs Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-49%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRPH's stock price target?
Not Available

PRPH doesn't have any price targets made by Wall Street professionals.

What is Prophase Labs Inc's Revenue forecast?
Projected CAGR
222%

For the last 13 years the compound annual growth rate for Prophase Labs Inc's revenue is -7%. The projected CAGR for the next 1 year is 222%.

Back to Top